US UK Business Law Advisors
For a UK founder, receiving a term sheet from a US venture capital firm is a major milestone, representing a serious expression of interest to invest. However, it is crucial to understand that a term sheet is not a definitive contract but rather a non-binding document that outlines the proposed terms and conditions of the investment. It serves as the blueprint for the definitive legal agreements that will follow. In the fast-paced world of US venture capital, the term sheet is a critical negotiation tool. Its terms will dictate the economic and control rights of the new investors and will have a lasting impact on the company’s future, including subsequent financing rounds and the ultimate exit. While some provisions, such as confidentiality, may be legally binding, the core of the term sheet is a statement of intent. UK founders, who may be more accustomed to the more detailed and often binding investment proposals common in the UK, must adapt to this American approach. The negotiation of the term sheet is where the key battle is won or lost. Once the term sheet is signed, the leverage shifts significantly to the investors, and it becomes very difficult to renegotiate major points. Therefore, a thorough understanding of every clause is essential before putting pen to paper. The structure of your company is a key consideration in this process, a topic we delve into in our article on theDelaware Flip vs US Subsidiary vs Branch.
The economic terms of a term sheet define the financial return for the investors and are often the most heavily negotiated. The pre-money valuation is the value of the company before the investment, and it determines the price per share that the investors will pay. While a higher valuation may seem attractive, an unrealistically high valuation can make it difficult to raise future rounds of financing at a higher price. The liquidation preference is another critical economic term. It determines the order in which shareholders get paid in the event of a liquidation or sale of the company. A standard “1x non-participating” preference means the investors get their money back first, and then the remaining proceeds are distributed among the common shareholders. More aggressive terms, such as a “participating” preference, allow investors to get their money backand share in the remaining proceeds, which can significantly reduce the return for founders and employees. Anti-dilution provisions protect investors from dilution if the company issues shares at a lower price in a future financing round. “Broad-based weighted average” anti-dilution is a common and founder-friendly formula, while more aggressive “full ratchet” anti-dilution can be highly dilutive to the founders. These economic terms are interconnected and must be evaluated as a package. A high valuation might be offset by an aggressive liquidation preference, so it is important to model out different exit scenarios to fully understand the financial implications. For founders new to US fundraising, understanding these instruments is key, as explained in our comparison ofSAFE Notes vs Convertible Notes.
Beyond the economics, a term sheet will also outline the control rights that the new investors will have. A common provision is the right for the lead investor to appoint one or more members to the company’s board of directors. The composition of the board is critical, as it is responsible for the overall governance and strategic direction of the company. Founders should strive to maintain a board composition that is balanced and not dominated by the investors. “Protective provisions” are another key set of control rights. These are essentially veto rights that give the investors the power to block certain corporate actions, even if they have been approved by the majority of the board or shareholders. Common protective provisions include the right to veto a sale of the company, a change in the company’s business, the issuance of new shares, or the taking on of debt. While it is reasonable for investors to have some level of protection, overly broad protective provisions can hamstring the company and make it difficult to operate efficiently. The scope of these provisions is a key point of negotiation. The term sheet will also specify the voting rights of the new class of shares being issued to the investors. Typically, the preferred shares issued to investors will vote together with the common shares on an as-converted basis, but they may also have separate class votes on certain matters.
A US venture capital term sheet will contain a number of other important clauses that UK founders need to understand. “Pro rata rights” give investors the right, but not the obligation, to participate in future financing rounds to maintain their percentage ownership in the company. This is a valuable right for investors and is a standard feature of most US VC deals. A “drag-along” clause allows the majority shareholders to force the minority shareholders to sell their shares in the event of a sale of the company. This is a common provision that is designed to prevent a small number of shareholders from blocking a strategic exit. The “no-shop” or “exclusivity” clause is one of the few legally binding provisions in a term sheet. It prevents the company from soliciting investment offers from other potential investors for a specified period, typically 30 to 60 days, while the lead investor conducts their due diligence and finalizes the legal documents. Founders should try to keep the no-shop period as short as possible to maintain their options. Understanding these and other clauses is essential for any UK founder navigating the US venture capital landscape. A well-negotiated term sheet can set the stage for a successful long-term partnership with your investors and provide the foundation for building a great company.
Share
Do you need legal help? Get in touch now!
We'll get back to you within 1 business day.
Jonathan’s practice focuses on representing UK, US and international clients in corporate transactions and private commercial matters, including Mergers and Acquisitions, corporate finance, joint ventures, recapitalizations and venture capital investments.